Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
68 Cards in this Set
- Front
- Back
calcium is involved in
|
bone/neuromuscular excitability, cardiac conduction, muscle contraction, secretion, coagulation, intercellular mediation, cellular adhenison 2nd messenger
|
|
control over calcium is tight/loose?
|
tight
|
|
phosphate roles
|
bone, membrane, nrg metab, nucleic acid polymerizaiton, maintenance of cell excitability and viabiltiy by ATP hydrolysis for ion pumping, extracellular buffering, regulation of cellffunction (proteing phosphyrlation/ getp hydrolysis0)
|
|
99% of bodiy's calcium is in
|
bone
|
|
extracellular vs intracellular calcium
|
intracellular 4 orders of magnitude less
|
|
what keeps intracellular ca low
|
na ca exchange and atp dependent ca 2+
|
|
bone remodeling
|
ostoclasts precursors activated by osteoblasts…. Recruited to sites in bone to diffentiate and fomre osteoclasts… resorb bone… preosteoblasts arrive, differntaite, osteoblast secrete osteoid collagen matrix; osteoblasts then secrete ca and p which are deposidted
|
|
osteoclast differentiate from
|
macrophage-monocyte lineatge
|
|
preosteoclasts hav ewhat kind of nucleus
|
mono- they fuse and form multi-nucleate osteoclasts and acquisition of secretory activity
|
|
RANKL
|
activates Rank
|
|
RANKL
|
receptor activator of NFKB
|
|
where is RANK L
|
surface protein of osteoblasts/stromal cells while rank is on osteoclast
|
|
MCSF
|
macrophage colony stimulating facort promotes osteoclast
|
|
rank l is induced by
|
pth and vitamin d during resorption
|
|
opg osteoprotegenir
|
on osteoblast
|
|
M-CSF is on
|
osteoblast stims osteoclast progenitor
|
|
PTH, 1,25 D; PGE2; IL1
|
all stimulate RANKL and OPG
|
|
the osteo clast bind to bone via
|
matrix integrins and then folrm a membrane
|
|
what passes through the osteoclased ruffled membrane
|
Cland H+ is pumped in.. Mobilizing bone
|
|
Cathepsin K
|
degrades demineralized protein component of bone… it's a lysososma protease
|
|
the deradation producst are processed how
|
endocytosed, transported to and released from the aniresorptive surface
|
|
BMP
|
bone morphogenic protein… most notable frowth factor for osteoblast
|
|
which step of osteoblast differntiation is stimulated by PTH and vitamin D?
|
both
|
|
how much Ca2+ circulating is active
|
50% the ionized form is the physiologic active form
|
|
what decreases protein bound calcium
|
cirrosis total drops but free same
|
|
what decreases diffusable calcium
|
citrate, phosphate komplex… usually is 7%
|
|
majro regulators of ca and PO4
|
claclitriol and PTH
|
|
minor regulator of Ca nd PO4
|
calcintonin
|
|
how to correct total plasma
|
correct total plasma ca by adding .8mg/dl for every mg/dl reduciton in serum albumin below normal
|
|
how does hypocalcemia cause excitability
|
remember the Ca+ lineed up outside the membrane, so it depolarizes when low
|
|
hypercalcemia symptoms
|
lethargy, drowsiness, coma, neuromsucular fatige and weakness, HTN brady cardia, arrythmias, nausea vomiting constipation, nephropathy, ectopic calcification
|
|
hypocalcemia symptoms
|
increased neuromuscular excitability; paraestheis, muscle cramps, tentany and convulsions… prolonged asphygiation due to laryngospasm
|
|
excessive sulights
|
degrade previtamin d3 and vitamin d3 into inactive photoproducts
|
|
25OHD3
|
calciferol
|
|
skin vit d rxn
|
7dehydrocholestorl to
|
|
pre d3 goes to
|
cholecalciferal (same that's absorbed
|
|
vitamin D2 and D3 transport from diet
|
chylomicrons transported by lymphatic into vensous
|
|
where is D2 or D3 stored
|
fat cells
|
|
how is vitamin d ciruclated
|
citamin d binding protedin
|
|
the major circulating forma f vitmaind
|
25(OH)D
|
|
vD-25 hydoxylase
|
converts vitamin d (D3, to 25OH3 (what's measured)
|
|
FGF-23 and vit amind D
|
FGF-23 decreases 1,25 (OH)2D synthessis as does 1,25 9OH)2D itself
|
|
what promotes 1,25 synthesis
|
low phosphate or low Ca2+
|
|
D-1 alpha hydroxylase
|
converts 25(OH)D to 1,25 (OH)2 D
|
|
vitamind d is a ligand for
|
VDR vitamin d receptor
|
|
Steroids and vitamin D
|
VDR is a transcription factor in the steroid-hromone superfacmilty of nuclrear transcriptional regulators
|
|
VDR distribution
|
wide
|
|
vit amind d and cell differentiation
|
has the potential to promote
|
|
the main stimulus for secterionof PTH
|
hypocalcemia
|
|
in familial hypercalcmin hypocalcurir what must happen
|
ca must rise to a higher level before inhibitn pth secertion
|
|
normal pth but high Ca
|
Familiaal hypercalcemic hypoclcuria
|
|
TRPV6
|
transcellular Ca pathway apical channel
|
|
Calbinding
|
intracellualr transcellular pathway
|
|
Ca?na exchanger
|
last step in intenstial transcellular pathway
|
|
what transcellular ca steps are stimulated by calcitriool
|
ll 3 , trpv5, ca/na xchg; calbindidn
|
|
major ca absorption route
|
not transcellular
|
|
calcitrio effects on bone
|
enhances phosphate mobilization directly, but indirectly (stimulates osteoblast differentiation) aids in bonode formation and by maintianng proper ca 2+ it aids in ineralization
|
|
calcitiorl effects on kidne
|
decreases excretion of clacium and phosphate
|
|
PTH1R recognizes
|
both PTH and PTHrP
|
|
PTH1R in
|
bone, kidney and proximal tubles
|
|
PTH1R is what type of receptr
|
G proteing
|
|
PTH or PTHrP binding to PTH1r indcuses
|
two g proteins Gs (PKA) and Gq (PKC)
|
|
intracellular messenter for PTH action in bone
|
cAMP in bone (Gs PKA cAMP)in kidney it's both PKA and PKS
|
|
PTH2R
|
recognizes only PTH, uncertain role
|
|
Calcitonin MOA
|
stimulate cAMP produint in bone and kidney however a requirement for cAMP in CT effects is not established
|
|
Calcitonin effects
|
direct inhibition of bone resorption and calcium and phosphatel 2. increases excretion of calcium and phosphate by the kidney
|
|
does calcitonin effect intestinal absorption?
|
no not of calcium or phosphate
|
|
calcitonin secreted
|
inresponse to hypercalcemia
|